Surgical treatment of hypertrophic cardiomyopathy

Sameh M. Said, Joseph A. Dearani, Steve R. Ommen, Hartzell V Schaff

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Hypertrophic cardiomyopathy (HCM) is a clinical entity in which there is unexplained hypertrophy of the left ventricle in the absence of another cardiac or systemic etiology. Variants of HCM may include basal, midventricular, apical or diffuse types. In this review, the authors summarize the current surgical treatment and outcomes of septal myectomy in HCM. HCM is a unique primary myocardial disease characterized by hypertrophy of the myocardium. It is associated with a variety of presentations that range from asymptomatic to sudden cardiac death. Previously known as idiopathic hypertrophic subaortic stenosis, HCM is recognized as a genetic predisposition to myocardial hypertrophy. Medical treatment is the first-line therapy for patients with symptoms due to left ventricular outflow tract obstruction. However, septal myectomy continues to be an excellent treatment option for those intolerant of or unresponsive to medical therapy. In this paper, the authors review the role of surgery in HCM and the different variants of this unique disease.

Original languageEnglish (US)
Pages (from-to)617-627
Number of pages11
JournalExpert Review of Cardiovascular Therapy
Volume11
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Hypertrophic Cardiomyopathy
Hypertrophy
Therapeutics
Ventricular Outflow Obstruction
Sudden Cardiac Death
Genetic Predisposition to Disease
Cardiomyopathies
Heart Ventricles
Myocardium
Pathologic Constriction

Keywords

  • apical myectomy
  • hypertrophic cardiomyopathy
  • midventricular obstruction
  • septal myectomy
  • systolic anterior motion
  • transapical myectomy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Surgical treatment of hypertrophic cardiomyopathy. / Said, Sameh M.; Dearani, Joseph A.; Ommen, Steve R.; Schaff, Hartzell V.

In: Expert Review of Cardiovascular Therapy, Vol. 11, No. 5, 05.2013, p. 617-627.

Research output: Contribution to journalArticle

Said, Sameh M. ; Dearani, Joseph A. ; Ommen, Steve R. ; Schaff, Hartzell V. / Surgical treatment of hypertrophic cardiomyopathy. In: Expert Review of Cardiovascular Therapy. 2013 ; Vol. 11, No. 5. pp. 617-627.
@article{cb30fcb3267942ceaa514238591632ce,
title = "Surgical treatment of hypertrophic cardiomyopathy",
abstract = "Hypertrophic cardiomyopathy (HCM) is a clinical entity in which there is unexplained hypertrophy of the left ventricle in the absence of another cardiac or systemic etiology. Variants of HCM may include basal, midventricular, apical or diffuse types. In this review, the authors summarize the current surgical treatment and outcomes of septal myectomy in HCM. HCM is a unique primary myocardial disease characterized by hypertrophy of the myocardium. It is associated with a variety of presentations that range from asymptomatic to sudden cardiac death. Previously known as idiopathic hypertrophic subaortic stenosis, HCM is recognized as a genetic predisposition to myocardial hypertrophy. Medical treatment is the first-line therapy for patients with symptoms due to left ventricular outflow tract obstruction. However, septal myectomy continues to be an excellent treatment option for those intolerant of or unresponsive to medical therapy. In this paper, the authors review the role of surgery in HCM and the different variants of this unique disease.",
keywords = "apical myectomy, hypertrophic cardiomyopathy, midventricular obstruction, septal myectomy, systolic anterior motion, transapical myectomy",
author = "Said, {Sameh M.} and Dearani, {Joseph A.} and Ommen, {Steve R.} and Schaff, {Hartzell V}",
year = "2013",
month = "5",
doi = "10.1586/erc.13.46",
language = "English (US)",
volume = "11",
pages = "617--627",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Surgical treatment of hypertrophic cardiomyopathy

AU - Said, Sameh M.

AU - Dearani, Joseph A.

AU - Ommen, Steve R.

AU - Schaff, Hartzell V

PY - 2013/5

Y1 - 2013/5

N2 - Hypertrophic cardiomyopathy (HCM) is a clinical entity in which there is unexplained hypertrophy of the left ventricle in the absence of another cardiac or systemic etiology. Variants of HCM may include basal, midventricular, apical or diffuse types. In this review, the authors summarize the current surgical treatment and outcomes of septal myectomy in HCM. HCM is a unique primary myocardial disease characterized by hypertrophy of the myocardium. It is associated with a variety of presentations that range from asymptomatic to sudden cardiac death. Previously known as idiopathic hypertrophic subaortic stenosis, HCM is recognized as a genetic predisposition to myocardial hypertrophy. Medical treatment is the first-line therapy for patients with symptoms due to left ventricular outflow tract obstruction. However, septal myectomy continues to be an excellent treatment option for those intolerant of or unresponsive to medical therapy. In this paper, the authors review the role of surgery in HCM and the different variants of this unique disease.

AB - Hypertrophic cardiomyopathy (HCM) is a clinical entity in which there is unexplained hypertrophy of the left ventricle in the absence of another cardiac or systemic etiology. Variants of HCM may include basal, midventricular, apical or diffuse types. In this review, the authors summarize the current surgical treatment and outcomes of septal myectomy in HCM. HCM is a unique primary myocardial disease characterized by hypertrophy of the myocardium. It is associated with a variety of presentations that range from asymptomatic to sudden cardiac death. Previously known as idiopathic hypertrophic subaortic stenosis, HCM is recognized as a genetic predisposition to myocardial hypertrophy. Medical treatment is the first-line therapy for patients with symptoms due to left ventricular outflow tract obstruction. However, septal myectomy continues to be an excellent treatment option for those intolerant of or unresponsive to medical therapy. In this paper, the authors review the role of surgery in HCM and the different variants of this unique disease.

KW - apical myectomy

KW - hypertrophic cardiomyopathy

KW - midventricular obstruction

KW - septal myectomy

KW - systolic anterior motion

KW - transapical myectomy

UR - http://www.scopus.com/inward/record.url?scp=84876945635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876945635&partnerID=8YFLogxK

U2 - 10.1586/erc.13.46

DO - 10.1586/erc.13.46

M3 - Article

C2 - 23621143

AN - SCOPUS:84876945635

VL - 11

SP - 617

EP - 627

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 5

ER -